Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05511051 | A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy | unknown | Phase 2 | 102 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 22, 2022 | clinicaltrials |
| NCT04966819 | Rectal Cancer Shared Care | unknown | N/A | 80 | Jewish General HospitalOTHER | 1 | Aug 19, 2022 |
| clinicaltrials |
| NCT04866108 | A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous Chemotherapy | unknown | Phase 2 | 49 | Beijing Friendship HospitalOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT05004831 | Fruquintinib Combined With TAS-102 in the Treatment of Patients With Advanced Metastatic CRC | unknown | Phase 2 | 54 | Sun Yat-sen UniversityOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT05016869 | Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 48 | Chinese Academy of Medical SciencesOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT04924179 | Tislelizumab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With Advanced CRC | unknown | Phase 2 | 25 | Huazhong University of Science and TechnologyOTHER | 1 | Aug 17, 2022 | clinicaltrials |
| NCT05495672 | Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules | unknown | N/A | 100 | Junjie PengOTHER | 1 | Aug 10, 2022 | clinicaltrials |
| NCT04598984 | The Role of Serum Adipokines in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer | unknown | — | 60 | Istanbul Training and Research HospitalOTHER_GOV | 1 | Aug 8, 2022 | clinicaltrials |
| NCT04857203 | The Role of Vitamin D in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer | unknown | — | 60 | Istanbul Training and Research HospitalOTHER_GOV | 1 | Aug 8, 2022 | clinicaltrials |
| NCT04127864 | Perioperative Immune Function in Patients Undergoing Colorectal Cancer Surgery(TruCulture) | unknown | — | 12 | University of CopenhagenOTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT05482529 | Integrative Omics Analysis for Colorectal Cancer and Metastasis | unknown | — | 20 | fan liOTHER | 1 | Aug 1, 2022 | clinicaltrials |
| NCT04869956 | Gut Microbiome Modification Through Dietary Intervention in Patients With Colorectal Cancer: Response to Surgery | unknown | N/A | 50 | Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaOTHER | 1 | Jul 27, 2022 | clinicaltrials |
| NCT04733963 | Fruquintinib Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer | unknown | Phase 2 | 112 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 26, 2022 | clinicaltrials |
| NCT04755907 | 3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases | unknown | — | 120 | Peking Union Medical College HospitalOTHER | 1 | Jul 19, 2022 | clinicaltrials |
| NCT05451719 | Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy | unknown | Phase 2 | 116 | Fudan UniversityOTHER | 0 | Jul 12, 2022 | clinicaltrials |
| NCT05447715 | Fruquintinib Sequential BEV+FOLFIRI vs. BEV+FOLFIRI Sequential Fruquintinib in Metastatic Colorectal Cancer | unknown | Phase 2 | 134 | Weijian GuoOTHER | 1 | Jul 7, 2022 | clinicaltrials |
| NCT04628182 | The China Laparoscopic Right Hemicolectomy SNAPSHOT | unknown | — | 1,579 | Beijing Friendship HospitalOTHER | 1 | Jun 30, 2022 | clinicaltrials |
| NCT05438108 | SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab in First-line Treatment of mCRC | unknown | Phase 2 | 30 | Huazhong University of Science and TechnologyOTHER | 1 | Jun 29, 2022 | clinicaltrials |
| NCT03668431 | Dabrafenib + Trametinib + PDR001 In Colorectal Cancer | unknown | Phase 2 | 25 | Massachusetts General HospitalOTHER | 1 | Jun 27, 2022 | clinicaltrials |
| NCT04750772 | Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer | unknown | N/A | 60 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jun 27, 2022 | clinicaltrials |
| NCT05099211 | Neuromuscular Deconditioning and Reconditioning in Colon Cancer Patients: an APA Muscle Rendorcement Program(REMUSCLON) | unknown | N/A | 60 | Centre Hospitalier Universitaire DijonOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05369312 | Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients | unknown | Phase 1 | 230 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05423886 | The Effectiveness of Personalized Colorectal Cancer Screening Based on Fecal Hemoglobin Concentration(PERFECT-FIT) | unknown | N/A | 20,000 | Esther Toes-ZoutendijkOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05424939 | Management of Obstructive Colon Tumors in Istanbul | unknown | — | 500 | Istanbul Medipol University HospitalOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT04637048 | Observational Study on Patients With Hepatobiliary Tumors | unknown | — | 1,000 | Gang Chen, MDOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT05422547 | Role of Immunoscore® in Stage II-III Colorectal Cancer | unknown | — | 100 | D'Or Institute for Research and EducationOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT02588781 | Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study | unknown | Phase 2 | 23 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02959541 | PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer | unknown | N/A | 48 | Vastra Gotaland RegionOTHER_GOV | 1 | Jun 13, 2022 | clinicaltrials |
| NCT03626922 | Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients | unknown | Phase 1 | 33 | NSABP Foundation IncNETWORK | 1 | Jun 10, 2022 | clinicaltrials |
| NCT05411783 | Low Tie Versus High Tie of the Inferior Mesenteric Vein During Colorectal Cancer Surgery: A Randomized Clinical Trial(LOTHVEIN) | unknown | N/A | 84 | San Carlo di Nancy HospitalOTHER | 1 | Jun 9, 2022 | clinicaltrials |
| NCT05409417 | Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status | unknown | Phase 2 / Phase 3 | 40 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 8, 2022 | clinicaltrials |
| NCT05408182 | Early Discharge After Robotic Colorectal Surgery (eRCS): a Prospective Observational Study(eRCS) | unknown | — | 100 | Ospedale di CamposampieroOTHER | 1 | Jun 7, 2022 | clinicaltrials |
| NCT05406206 | Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy | unknown | Phase 2 | 27 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jun 6, 2022 | clinicaltrials |
| NCT05402124 | The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study | unknown | Phase 2 | 100 | University of CalgaryOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT05387876 | Vitamin D Intervention and Associated Changes in the Gut Microbiome and Vitamin D Levels in Healthy Adults(VDMT) | unknown | N/A | 43 | Baylor UniversityOTHER | 1 | May 24, 2022 | clinicaltrials |
| NCT05382377 | NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors | unknown | Early Phase 1 | 18 | jianming xuOTHER | 1 | May 19, 2022 | clinicaltrials |
| NCT03863236 | A Study of Perioperative Oral Nutritional Support for Patients Having Surgery for Colon Cancer, Peri-Nutri | unknown | N/A | 318 | University of OuluOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT04599920 | Effects of Replacing Red Meat With Legumes on Biomarkers of Chronic Diseases in Healthy Men (Leg4Life) | unknown | N/A | 100 | University of HelsinkiOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT05378867 | A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC(CRC) | unknown | Phase 3 | 126 | Zhejiang Teruisi Pharmaceutical Inc.INDUSTRY | 0 | May 18, 2022 | clinicaltrials |
| NCT04235556 | Integrated Care Pathway in Oncology (PASSION)(PASSION) | unknown | — | 1,800 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 13, 2022 | clinicaltrials |
| NCT05365256 | Impact of Virtual Reality on the Mental Health of Patients Undergoing Adjuvant Treatment for Colorectal Cancer(VIRECAPS2) | unknown | N/A | 98 | GCS Ramsay Santé pour l'Enseignement et la RechercheOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT05371197 | Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer | unknown | Phase 2 | 26 | Third Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT05367284 | Perioperative Testosterone Replacement Therapy in Sarcopenic Male Colorectal Cancer Patients(TERESA) | unknown | — | 30 | London North West Healthcare NHS TrustOTHER | 1 | May 10, 2022 | clinicaltrials |
| NCT03411707 | Multiple Screening Methods for the Detection of Chinese Colorectal Advanced Adenomatous Polyps and Cancer | unknown | — | 1,200 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | May 6, 2022 | clinicaltrials |
| NCT05362617 | mFOLXOX6 Versus FOLFIRI for Colorectal Patients Recurrence After Oxaplatin Based Adjuvant Chemotherapy | unknown | Phase 3 | 328 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT03794193 | The Effect of Unfavorable Histological Features on the Oncological Outcomes of Colon Cancer | unknown | — | 1,367 | Peking Union Medical College HospitalOTHER | 0 | May 4, 2022 | clinicaltrials |
| NCT05154474 | Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy(SPACE2) | unknown | — | 150 | WepromOTHER | 1 | May 3, 2022 | clinicaltrials |
| NCT02562963 | Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 120 | Minghui ZhangOTHER | 1 | May 2, 2022 | clinicaltrials |
| NCT05353582 | Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases | unknown | Phase 2 | 168 | Sun Yat-sen UniversityOTHER | 1 | Apr 29, 2022 | clinicaltrials |
| NCT05354817 | Impact of FOLFIRINOX Chemotherapy in IV Stage Colorectal Cancer Patients Previously Exposed to Irinotecan, Fluoropyrimidine and Oxaliplatin(Re-Play) | unknown | Phase 2 | 25 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 29, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Aug 22, 2022source: clinicaltrials